Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $2.08 million. The enterprise value is -$12.05 million.
| Market Cap | 2.08M |
| Enterprise Value | -12.05M |
Important Dates
The last earnings date was Thursday, September 10, 2026, after market close.
| Earnings Date | Sep 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 420,883 shares outstanding.
| Current Share Class | 420,883 |
| Shares Outstanding | 420,883 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +423.95% |
| Owned by Insiders (%) | 6.42% |
| Owned by Institutions (%) | 1.46% |
| Float | 393,865 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.11 |
| P/TBV Ratio | 0.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.31, with a Debt / Equity ratio of 0.14.
| Current Ratio | 4.31 |
| Quick Ratio | 4.28 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,196.98 |
Financial Efficiency
Return on equity (ROE) is -106.98% and return on invested capital (ROIC) is -69.96%.
| Return on Equity (ROE) | -106.98% |
| Return on Assets (ROA) | -53.08% |
| Return on Invested Capital (ROIC) | -69.96% |
| Return on Capital Employed (ROCE) | -67.93% |
| Weighted Average Cost of Capital (WACC) | 4.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $12,695 in taxes.
| Income Tax | 12,695 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.71% in the last 52 weeks. The beta is 0.51, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -97.71% |
| 50-Day Moving Average | 6.71 |
| 200-Day Moving Average | 11.22 |
| Relative Strength Index (RSI) | 28.17 |
| Average Volume (20 Days) | 6,526 |
Short Selling Information
The latest short interest is 3,861, so 0.92% of the outstanding shares have been sold short.
| Short Interest | 3,861 |
| Short Previous Month | 14,819 |
| Short % of Shares Out | 0.92% |
| Short % of Float | 0.98% |
| Short Ratio (days to cover) | 0.11 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.87M |
| Pretax Income | -7.48M |
| Net Income | -7.50M |
| EBITDA | -8.86M |
| EBIT | -8.87M |
| Earnings Per Share (EPS) | -$118.41 |
Balance Sheet
The company has $15.93 million in cash and $1.80 million in debt, with a net cash position of $14.13 million or $33.58 per share.
| Cash & Cash Equivalents | 15.93M |
| Total Debt | 1.80M |
| Net Cash | 14.13M |
| Net Cash Per Share | $33.58 |
| Equity (Book Value) | 12.95M |
| Book Value Per Share | 48.30 |
| Working Capital | 12.77M |
Cash Flow
| Operating Cash Flow | -7.07M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 10,954 |
| Net Borrowing | 10.08M |
| Free Cash Flow | -7.07M |
| FCF Per Share | -$16.80 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CMND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2,392.12% |
| FCF Yield | -313.95% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 5, 2026. It was a reverse split with a ratio of 1:8.
| Last Split Date | Oct 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |